aTyr Pharma, Inc. (ATYR)
$0.25-3.85%Close
SELLCRISIS · day 28
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $25M
- Beta
- 0.53
- P/E (TTM)
- -0.46
- Short % float
- 13.50%
- Days to cover
- 1.0
- SI change
- +20.9%
- 1W
- -13.79%
- 1M
- -41.86%
- vs SPY 1W
- -14.95%
- vs SPY 1M
- -44.85%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ATYR?
- LOPJLB’s latest quantitative signal on aTyr Pharma, Inc. (ATYR) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ATYR in?
- aTyr Pharma, Inc. (ATYR) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does aTyr Pharma, Inc. (ATYR) do?
- aTyr Pharma, Inc., a biopharmaceutical firm established in San Diego, California, in 2005, is dedicated to the discovery and advancement of therapeutic solutions. Operating within the United States, the company's research focuses on pioneering novel immunological pathways to address various medical conditions. Its primary investigational drug, efzofitimod, functions as a selective modulator of …